Quick Answer
Tanke Biosciences Corp reported Stockholders Equity of $15.75 million for fiscal year 2012.
Tanke Biosciences Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2012 | $15.75M | -0.6% |
| 2011 | $15.85M | +94.2% |
| 2010 | $8.16M | +26.8% |
| 2009 | $6.44M | +70.5% |
| 2008 | $3.77M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2013 | $15.56M | -5.9% | -1.0% |
| June 30, 2013 | $15.71M | — | +3.3% |
| March 31, 2013 | $15.21M | -0.6% | -3.5% |
| December 31, 2012 | $15.75M | -0.6% | -4.7% |
| September 30, 2012 | $16.53M | — | +8.1% |
| March 31, 2012 | $15.30M | — | -3.5% |
| December 31, 2011 | $15.85M | — | — |
- Tanke Biosciences Corp showed a decrease of -0.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2012 period, Tanke Biosciences Corp’s stockholders equity has grown by 317.3% (from $3.77 million to $15.75 million).
- The most recent figure is from Tanke Biosciences Corp’s fiscal year 2012 report (Form 10-K), filed with the SEC on April 15, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: